130 related articles for article (PubMed ID: 8645677)
1. A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours.
Finlay PM; Richardson MD; Robertson AG
Br J Oral Maxillofac Surg; 1996 Feb; 34(1):23-5. PubMed ID: 8645677
[TBL] [Abstract][Full Text] [Related]
2. A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidosis. Multicentre Study Group.
Taillandier J; Esnault Y; Alemanni M
Age Ageing; 2000 Mar; 29(2):117-23. PubMed ID: 10791445
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the efficacy and safety of fluconazole oral suspension and amphotericin B oral suspension in cancer patients with mucositis.
Lefebvre JL; Domenge C;
Oral Oncol; 2002 Jun; 38(4):337-42. PubMed ID: 12076696
[TBL] [Abstract][Full Text] [Related]
4. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy.
Ramirez-Amador V; Silverman S; Mayer P; Tyler M; Quivey J
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Aug; 84(2):149-53. PubMed ID: 9269016
[TBL] [Abstract][Full Text] [Related]
5. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
Fichtenbaum CJ; Zackin R; Rajicic N; Powderly WG; Wheat LJ; Zingman BS
AIDS; 2000 May; 14(7):845-52. PubMed ID: 10839593
[TBL] [Abstract][Full Text] [Related]
6. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
[TBL] [Abstract][Full Text] [Related]
7. Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.
Quereda C; Polanco AM; Giner C; Sánchez-Sousa A; Pereira E; Navas E; Fortún J; Guerrero A; Baquero F
Eur J Clin Microbiol Infect Dis; 1996 Jan; 15(1):30-7. PubMed ID: 8641300
[TBL] [Abstract][Full Text] [Related]
8. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
9. Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis.
Arikan S; Akova M; Hayran M; Ozdemir O; Erman M; Gür D; Unal S
Clin Infect Dis; 1998 Apr; 26(4):903-8. PubMed ID: 9564473
[TBL] [Abstract][Full Text] [Related]
10. Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer.
Redding SW; Kirkpatrick WR; Coco BJ; Sadkowski L; Fothergill AW; Rinaldi MG; Eng TY; Patterson TF
J Clin Microbiol; 2002 May; 40(5):1879-81. PubMed ID: 11980984
[TBL] [Abstract][Full Text] [Related]
11. A comparison of fluconazole and itraconazole in the management of denture stomatitis: a pilot study.
Cross LJ; Bagg J; Wray D; Aitchison T
J Dent; 1998 Nov; 26(8):657-64. PubMed ID: 9793287
[TBL] [Abstract][Full Text] [Related]
12. Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial.
Corvò R; Amichetti M; Ascarelli A; Arcangeli G; Buffoli A; Cellini N; Cionini L; De Renzis C; Emiliani E; Franchini P; Gabriele P; Gobitti C; Grillo Ruggieri F; Bertoni F; Magrini SM; Marmiroli L; Orsatti M; Panizza GM; Tordiglione M; Ziccarelli L; Gava A; Zorat PL; Ghelfi R; Serra GF; Vitale V
Eur J Cancer Care (Engl); 2008 May; 17(3):270-7. PubMed ID: 18419630
[TBL] [Abstract][Full Text] [Related]
13. [Oral amphotericin B inefficacy in the treatment of fluconazole++ resistant oropharyngeal candidiasis in HIV-positive patients].
Laguna F; Valencia E; Polo R; Moreno V; González-Lahoz JM
Rev Clin Esp; 1996 Dec; 196(12):878-9. PubMed ID: 9132869
[No Abstract] [Full Text] [Related]
14. Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck cancers.
Koc M; Aktas E
Jpn J Clin Oncol; 2003 Feb; 33(2):57-60. PubMed ID: 12629054
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
[TBL] [Abstract][Full Text] [Related]
16. Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
Petraitis V; Petraitiene R; Groll AH; Sein T; Schaufele RL; Lyman CA; Francesconi A; Bacher J; Piscitelli SC; Walsh TJ
Antimicrob Agents Chemother; 2001 Feb; 45(2):471-9. PubMed ID: 11158743
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and treatment management of oropharyngeal candidiasis in cancer patients: results of the French CANDIDOSCOPE study.
Gligorov J; Bastit L; Gervais H; Henni M; Kahila W; Lepille D; Luporsi E; Sasso G; Varette C; Azria D;
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):532-9. PubMed ID: 20594986
[TBL] [Abstract][Full Text] [Related]
18. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.
Pons V; Greenspan D; Lozada-Nur F; McPhail L; Gallant JE; Tunkel A; Johnson CC; McCarty J; Panzer H; Levenstein M; Barranco A; Green S
Clin Infect Dis; 1997 Jun; 24(6):1204-7. PubMed ID: 9195083
[TBL] [Abstract][Full Text] [Related]
19. Itraconazole and fluconazole in oropharyngeal candidiasis.
van der Bijl P; Arendorf TM
Ann Dent; 1993; 52(2):12-6. PubMed ID: 8267372
[TBL] [Abstract][Full Text] [Related]
20. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
